GC Cell Corporation
Records under this name other than the patents GC Cell Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 3 of 3 · Back to GC Cell Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,410,261 | Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,116,417 | ANTI-HER2 Antibody or Antigen-Binding Fragment Thereof, and Chimeric Antigen Receptor Comprising Same Formerly held In force · High confidence | In force | High confidence | |
| US 12,398,372 | Method for Culturing Cord Blood-Derived Natural Killer Cells Using Transformed T-Cells Formerly held In force · High confidence | In force | High confidence |